Fig. 1
From: Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology
Expression of CK2 in the hippocampus and temporal cortex. Protein expression of CK2 was assessed by Western blot analysis using mouse anti-CK2 which detects both CK2α and CK2α’ (see Additional file 2: Figure S1). a Western blot analysis of brain extracts from the hippocampus. b Western blot analysis of brain extracts from the temporal cortex. AD and non-demented control (CON) cases analysed by Western blotting are listed in Table 1. Braak stages are indicated, and recombinant CK2α and CK2α’ were used as positive controls. Ponceau red staining was used in order to determine the relative protein load on the blotting membrane. c Quantification of CK2α/α’ expression in the hippocampus of AD and control cases. d Quantification of CK2α/α’ protein expression in the temporal cortex. Shown are mean levels +/− SD